Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study

Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study

Purpose: This study provides a comparative survival analysis between the only two drugs approved in Italy for the treatment of moderate-to-severe AD, cyclospoorin, and dupilumab. Materials and methods: A multicenter, retrospective study, was performed to assess drug survival (DS) analysis by compari...

Full description

Bibliographic Details
Main Authors: Maddalena Napolitano, Maria Mariano, Antonio Cristaudo, Stefano Dastoli, Adriana Di Guida, Mario De Lucia, Gianluca Guerrasio, Steven Paul Nisticò, Maria Passante, Flavia Pigliacelli, Gabriella Fabbrocini, Cataldo Patruno
Format: Article
Language:English
Published: Taylor & Francis Group 2022-07-01
Series:Journal of Dermatological Treatment
Subjects:
dupilumab
cyclosporine
drug survival
immunosuppressive therapies
safety
Online Access:http://dx.doi.org/10.1080/09546634.2022.2067818

Internet

http://dx.doi.org/10.1080/09546634.2022.2067818

Similar Items